Meichen Zhang

CXCR4 and CD44 dual-targeted Prussian blue nanosystem with daunorubicin loaded for acute myeloid leukemia therapy

Yu Zhang, N. Gu, Haiyan Xu, 2021 .

Prussian blue nanoparticles induce myeloid leukemia cells to differentiate into red blood cells through nanozyme activities.

J. Meng, Yu Zhang, Jian Liu, 2020, Nanoscale.

CD123 Antagonistic Peptides Assembled with Nanomicelles Act as Monotherapeutics to Combat Refractory Acute Myeloid Leukemia.

J. Meng, Jian Liu, Haiyan Xu, 2022, ACS applied materials & interfaces.

Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia.

J. Meng, Jian Liu, Haiyan Xu, 2022, Pharmacological research.

A novel CD123-targeted therapeutic peptide loaded by micellar delivery system combats refractory acute myeloid leukemia

J. Meng, Jian Liu, Haiyan Xu, 2021, Journal of Hematology & Oncology.

Iron oxide nanoparticles cause surface coating- and core chemistry-dependent endothelial cell ferroptosis

J. Meng, Jian Liu, Haiyan Xu, 2022, Nanotoxicology.

Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy

Haiyan Xu, Meichen Zhang, 2023, Frontiers in Chemistry.